When the COVID-19 pandemic arrived in the United States in 2020, the American research community experienced a sudden spike in funding. Universities, pharmaceutical companies, and state and federal ...

BSL-2 is designed for work with agents that pose moderate hazards to personnel and the environment. These agents are associated with human diseases that are generally treatable or preventable. Agents ...

The MarketWatch News Department was not involved in the creation of this content. Many modern medicines rely on biologic and genetic materials, such as proteins, viral vectors, and DNA/mRNA, rather ...

BSL yields 9.53% and pays monthly. Management has raised the monthly dividends three times in the past five months. BSL and some other floating rate funds are selling at deeper than historic discounts ...

The complexity of medical and drug products that we are seeing today are often based on unique and attenuated microbe-based agents that require special handling thus ...